Purchase Order HHSN268201700175A

This federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award is a $57,600.00 firm-fixed-price delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is for the generation of a non-conditional genetically modified mouse strain,...

Synthego Corporation will deliver customized human cell lines to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under a $22,650 firm fixed price purchase order. Specifically, Synthego will supply vials of immortalized THP-1 cells containing a single nucleotide variant or codon change in the protein coding sequence of an unspecified chromosome. The estimated turnaround time is 17 weeks for this small cell clone order placed under NIAMS' research support...

This federal contract award, valued at $3,869.87, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the procurement of mouse antibodies, which are likely to support various biomedical research and public health initiatives at NIAID and other agencies within the Department of Health and Human Services (HHS)....

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...

This federal contract award, valued at $13,594.30, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, to perform in vivo mouse experiments using the TMPRSS2 flox strain. The goal is to study the function and underlying mechanism of the TMPRSS2 protein under the intestinal mucosal...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to Cyagen Biomodels LLC for a project to conditionally knockout mouse WNK1 and STK10 genes using CRISPR/Cas9 technology. Work will be performed by Cyagen Biomodels LLC Division in Santa Clara, California over a period of four months concluding in late December 2023. The award was made to the prime contractor Cyagen...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing, custom design chimeric plasmid, and custom proteins. The $249,785.00 contract has a completion date of September 29, 2022 and was awarded on September 30, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...

The Department of Health and Human Services' National Institutes of Health's National Center for Advancing Translational Sciences awarded a $13,474 purchase order to Horizon Discovery Biosciences Limited of Great Britain. Under the firm fixed price contract, Horizon Discovery will provide ON-TARGETPLUS MOUSE AAK1 small interfering RNA SMARTPOOL consisting of 50 nanomoles of the described product. Place of performance will be Great Britain, with work occurring between September 5 and November...

This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,453 purchase order to Genscript USA Inc. to provide custom peptide synthesis services in support of H1/HA programs. The firm fixed price contract runs from September 18, 2023 through December 29, 2023 and will be performed in Piscataway, New Jersey. Genscript will synthesize peptides to advance NIH's research on influenza viruses under the contract....